Latest Press Mentions
POWERFUL COVID-19 RESEARCH TOOL: SCIENTISTS CREATE NONINFECTIOUS VERSIONS OF SARS-COV-2
October 20, 2021
To study a virus as infectious as SARS-CoV-2, researchers need to follow laborious protocols and have access to high-biosafety laboratories. Seeking to make such investigations safer, faster, and accessible to more teams around the world, virologists have created SARS-CoV-2 replicons—self-replicating RNAs that are not infectious but otherwise identical to the real virus. The study is published in the journal Science.
SARS-COV-2 VIRUS NEEDS TMEM106B TO INFECT HUMAN CELLS
March 11, 2021
Three groups converge on the same SARS-CoV-2 host factor, TMEM106B, a genetic risk factor for frontotemporal dementia and Alzheimer’s disease.
POTENTIAL WEAKNESSES FOUND IN SARS-COV-2 INFECTION
December 10, 2020
A single protein that appears necessary for the coronavirus disease (COVID-19) virus to reproduce and spread to other cells is a potential weakness that could be targeted by future therapies.
BONNIE J. ADDARIO LUNG CANCER FOUNDATION ANNOUNCES RECIPIENTS OF THE SECOND ANNUAL YOUNG INNOVATORS TEAM AWARD FOR LUNG CANCER RESEARCH
July 7, 2016
The Bonnie J. Addario Lung Cancer Foundation (ALCF) and the Van Auken Private Foundation (VAPF) announced the recipients of the second annual ALCF-VAPF Young Innovators Team Award (YITA).
LUNGEVITY FOUNDATION 2014 CAREER DEVELOPMENT AWARDS FOR LUNG CANCER RESEARCH
July 9, 2014
LUNGevity Foundation today announced the recipients of its 2014 Career Development Awards for Translational Research.